Research output per year
Research output per year
- 29 results
Search results
-
2023
ASO Author Reflections: Towards Consensus on Resectability Assessments and Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases
Bond, M. J. G., Punt, C. J. A. & Swijnenburg, R-J., Sept 2023, In: Annals of surgical oncology. 30, 9, p. 5386-5387 2 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access -
2022
Reply to R. Pham et al
van 't Erve, I., Punt, C. J. A., Meijer, G. A. & Fijneman, R. J. A., 1 Mar 2022, In: JCO Precision Oncology. 6, e2200053.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access -
2021
Erratum: Stromal-derived interleukin 6 drives epithelialto- mesenchymal transition and therapy resistance in esophageal adenocarcinoma (Proc. Natl. Acad. Sci. U.S.A. (2019) 116 (2237-2242) DOI: 10.1073/pnas.1820459116)
Ebbing, E. A., van der Zalm, A. P., Steins, A., Creemers, A., Hermsen, S., Rentenaar, R., Klein, M., Waasdorp, C., Meijer, S. L., Krishnadath, K. K., Punt, C. J. A., van Berge Henegouwen, M. I., Gisbertz, S. S., van Delden, O. M., Hulshof, M. C. C. M., Medema, J. P., van Laarhoven, H. W. M. & Bijlsma, M. F., 14 Sept 2021, In: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 118, 37, e2113728118.Research output: Contribution to journal › Comment/Letter to the editor › Academic
Open Access -
Limitations of the PRODIGE 7 trial
Rovers, K. P., Kok, N. F. M., Punt, C. J. A., Tanis, P. J. & de Hingh, I. H. J. T., 1 May 2021, In: lancet oncology. 22, 5, p. e174Research output: Contribution to journal › Comment/Letter to the editor › Academic
5 Citations (Scopus) -
2020
Duration of adjuvant treatment for patients with stage III colon cancer
Koopman, M. & Punt, C. J. A., 1 Dec 2020, In: lancet oncology. 21, 12, p. 1545-1547 3 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
1 Citation (Scopus) -
2019
Genome-wide cell-free DNA fragmentation in patients with cancer
Cristiano, S., Leal, A., Phallen, J., Fiksel, J., Adleff, V., Bruhm, D. C., Jensen, S. Ø., Medina, J. E., Hruban, C., White, J. R., Palsgrove, D. N., Niknafs, N., Anagnostou, V., Forde, P., Naidoo, J., Marrone, K., Brahmer, J., Woodward, B. D., Husain, H., van Rooijen, K. L., & 16 others, 20 Jun 2019, In: NATURE. 570, 7761, p. 385-389 5 p.Research output: Contribution to journal › Comment/Letter to the editor › Academic
643 Citations (Scopus) -
Updated Survival Analysis of the Randomized Phase III Trial of S-1 Versus Capecitabine in the First-Line Treatment of Metastatic Colorectal Cancer by the Dutch Colorectal Cancer Group
Kwakman, J. J. M., van Werkhoven, E., Simkens, L. H. J., van Rooijen, J. M., van de Wouw, Y. A. J., Tije, A. J. T., Creemers, G-J. M., Hendriks, M. P., Los, M., van Alphen, R. J., Polée, M. B., Muller, E. W., van der Velden, A. M. T., van Voorthuizen, T., Koopman, M., Mol, L. & Punt, C. J. A., 2019, In: Clinical Colorectal Cancer. 18, 2, p. e229-e230Research output: Contribution to journal › Comment/Letter to the editor › Academic
4 Citations (Scopus) -
2018
Pseudoprogression on bevacizumab treatment: tumor-dynamics in the modern era of systemic treatment for metastatic colorectal cancer
Punt, C. J. A., Huiskens, J., van Gulik, T. & Engelbrecht, M., 2018, In: Acta oncologica (Stockholm, Sweden). 57, 5, p. 681-682Research output: Contribution to journal › Comment/Letter to the editor › Academic
5 Citations (Scopus) -
2017
Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients
Kwakman, J. J. M., Baars, A., Boot, H., Pruijt, J. F. M., Winther, S. B., Pfeiffer, P. & Punt, C. J. A., 2017, In: Acta oncologica (Stockholm, Sweden). 56, 7, p. 1023-1026Research output: Contribution to journal › Comment/Letter to the editor › Academic
11 Citations (Scopus) -
2016
RE: Effects of adjuvant chemotherapy on recurrence, survival and quality of life in stage II colon cancer patients: a 24-month follow-up
van Erning, F. N., Vissers, P. A. J., Punt, C. J. A. & Lemmens, V. E. P. P., 2016, In: Supportive Care in Cancer. 24, 10, p. 4079-4080Research output: Contribution to journal › Comment/Letter to the editor › Academic
9 Citations (Scopus) -
2015
Maintenance treatment in metastatic colorectal cancer
Simkens, L. H. J., van Tinteren, H., Punt, C. J. A. & Koopman, M., 2015, In: lancet oncology. 16, 16, p. e582-e583Research output: Contribution to journal › Comment/Letter to the editor › Academic
2 Citations (Scopus) -
RE: Generalizability of Trial Results to Elderly Medicare Patients With Advanced Solid Tumors
Mol, L., Koopman, M., Ottevanger, P. B. & Punt, C. J. A., 2015, In: Journal of the National Cancer Institute. 107, 6, p. djv104Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
2013
Capecitabine, irinotecan (CAPIRI) and sunitinib in metastatic colorectal cancer
Boers-Sonderen, M. J., Desar, I. M. E., Koopman, M., Punt, C. J. & van Herpen, C. M. L., 2013, In: Acta oncologica (Stockholm, Sweden). 52, 8, p. 1778-U1779Research output: Contribution to journal › Comment/Letter to the editor › Academic
1 Citation (Scopus) -
2012
Reply letter to: Signet ring cell carcinoma as a potential confounding factor in the analysis of outcomes with colorectal mucinous adenocarcinoma
Mekenkamp, L. J. M., Heesterbeek, C. J., Punt, C. J. A. & Nagtegaal, I. D., 2012, In: European journal of cancer (Oxford, England. 48, 16, p. 3128-3129Research output: Contribution to journal › Comment/Letter to the editor › Academic
2 Citations (Scopus) -
2011
Bevacizumab and cancer treatment-related mortality
Punt, C. J. A., Mol, L. & Koopman, M., 2011, In: JAMA. 305, 22, p. 2292; author reply 2292-2292; author reply 2293Research output: Contribution to journal › Comment/Letter to the editor › Academic
2 Citations (Scopus) -
2010
Regarding: 'Explorative study to identify novel candidate genes related to oxaliplatin efficacy and toxicity using a DNA repair array'
Pander, J., Gelderblom, H., van der Straaten, T., Punt, C. J. A. & Guchelaar, H-J., 2010, In: British journal of cancer. 102, 12, p. 1791-1792Research output: Contribution to journal › Comment/Letter to the editor › Academic
-
The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab
Simkens, L. H. J., Tol, J., Terstappen, L. W. M. M., Teerenstra, S., Punt, C. J. A. & Nagtegaal, I. D., 2010, In: Annals of Oncology. 21, 12, p. 2447-2448Research output: Contribution to journal › Comment/Letter to the editor › Academic
31 Citations (Scopus) -
2009
BRAF mutation in metastatic colorectal cancer
Tol, J., Nagtegaal, I. D. & Punt, C. J. A., 2009, In: New England journal of medicine. 361, 1, p. 98-99Research output: Contribution to journal › Comment/Letter to the editor › Academic
438 Citations (Scopus) -
The CAIRO and FOCUS studies: which lesson is to be learned?
Koopman, M., Seymour, M. T. & Punt, C. J. A., 2009, In: oncologist. 14, 2, p. 192-3; author reply 194-6Research output: Contribution to journal › Comment/Letter to the editor › Academic
8 Citations (Scopus) -
Vascular endothelial growth factor in systemic capillary leak syndrome
Lesterhuis, W. J., Rennings, A. J., Leenders, W. P., Nooteboom, A., Punt, C. J., Sweep, F. C., Pickkers, P., Geurts-Moespot, A., van Laarhoven, H. W., van der Vlag, J., Berden, J. H., Postma, C. T. & van der Meer, J. W., 2009, In: American journal of medicine. 122, 6, p. e5-e7Research output: Contribution to journal › Comment/Letter to the editor › Academic
58 Citations (Scopus) -
2008
Capecitabine and irinotecan as first-line treatment of advanced colorectal cancer
Punt, C. J. A. & Koopman, M., 2008, In: Journal of clinical oncology. 26, 11, p. 1907-8; author reply 1908-9Research output: Contribution to journal › Comment/Letter to the editor › Academic
27 Citations (Scopus) -
2007
CAIRO and FOCUS
Seymour, M. T. & Punt, C. J. A., 2007, In: Lancet. 370, 9603, p. 1904-5; author reply 1905Research output: Contribution to journal › Comment/Letter to the editor › Academic
7 Citations (Scopus) -
1995
Fotemustine and tamoxifen combination therapy in metastatic malignant melanoma. A phase II study
Punt, C. J., Tytgat, J. H., van Liessum, P. A. & Gerard, B., 1995, In: European journal of cancer (Oxford, England. 31A, 3, p. 421-422Research output: Contribution to journal › Comment/Letter to the editor › Academic
2 Citations (Scopus) -
Paclitaxel-induced severe hypersensitivity reaction occurring as a late toxicity
van Herpen, C. M., van Hoesel, Q. G. & Punt, C. J., 1995, In: Annals of Oncology. 6, 8, p. 852Research output: Contribution to journal › Comment/Letter to the editor › Academic
8 Citations (Scopus) -
Spontaneous fracture of implanted central venous catheters in cancer patients: report of two cases and retrospective analysis of the 'pinch-off sign' as a risk factor
Punt, C. J., Strijk, S., van der Hoeven, J. J., van de Sluis, R. & Verhagen, C. A., 1995, In: Anti-Cancer Drugs. 6, 4, p. 594-598Research output: Contribution to journal › Comment/Letter to the editor › Academic
16 Citations (Scopus) -
1994
Severe asthenia and fatigue caused by recombinant human granulocyte colony-stimulating factor (rh G-CSF)
Punt, C. J. & Kingma, B. J., 1994, In: Annals of Oncology. 5, 5, p. 473Research output: Contribution to journal › Comment/Letter to the editor › Academic
3 Citations (Scopus) -
1992
Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study
Punt, C. J., de Mulder, P. H., Burghouts, J. T. & Wagener, D. J., 1992, In: Cancer Chemotherapy and Pharmacology. 29, 4, p. 326-328Research output: Contribution to journal › Comment/Letter to the editor › Academic
6 Citations (Scopus) -
1990
Acute fatal leukoencephalopathy after interleukin-2 therapy
Vecht, C. J., Keohane, C., Menon, R. S., Punt, C. J. & Stoter, G., 1990, In: New England journal of medicine. 323, 16, p. 1146-1147Research output: Contribution to journal › Comment/Letter to the editor › Academic
48 Citations (Scopus) -
Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)
Punt, C. J., Henzen-Logmans, S. C., Bolhuis, R. L. & Stoter, G., 1990, In: British journal of cancer. 61, 3, p. 491Research output: Contribution to journal › Comment/Letter to the editor › Academic
10 Citations (Scopus)